Overview
Peter Hammerman is an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Hammerman is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
He is actively involved in clinical research, co-authoring 95 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Dana-Farber Cancer Institute
Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Choueiri is currently accepting new patients.
Frequently Asked Questions about Dr. Peter S. Hammerman
How do I make an appointment with Dr. Peter S. Hammerman?
You can book an appointment with Dr. Peter S. Hammerman by calling their office at 617-632-5301. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Peter S. Hammerman a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter S. Hammerman is classified as an Distinguished expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Peter S. Hammerman specialize in?
While Dr. Peter S. Hammerman is a Oncology, they have specific expertise in Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Peter S. Hammerman participate in research or clinical trials?
Yes. Dr. Peter S. Hammerman has published 95 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Dr. Peter S. Hammerman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerDr. Hammerman isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Hammerman isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hammerman isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Hammerman isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Hammerman isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Hammerman isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Hammerman isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hammerman isAdvanced. Learn about Large-Cell Lung Carcinoma.
- PIK3CA-Related Overgrowth SpectrumDr. Hammerman isAdvanced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Pleuropulmonary BlastomaDr. Hammerman isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Head and Neck Squamous Cell Carcinoma (HNSCC)Dr. Hammerman isExperienced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- MesotheliomaDr. Hammerman isExperienced. Learn about Mesothelioma.
- Tongue CancerDr. Hammerman isExperienced. Learn about Tongue Cancer.
- Urothelial CancerDr. Hammerman isExperienced. Learn about Urothelial Cancer.